|
|
|
|
: Ͽ Ʋ 5:2 ܽġ̾Ʈ ̷ ȿ |
ϾϿ͡Ƣմ , 5:2 ܽ, ü ȿ ־̻ 氣 ġ ȿ ־Ͽ Ʋ 5:2 ܽ ġῡ ȿ ִٴ Դ. (A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPAR and PCK1, 5:2 ܽ PPAR PCK1 ڿü 氣 ȭ ϰ ߴ Ѵ) м Ÿ(Cell Metabolism) ֱ ƴ.
ϾϿ(German Cancer Research Center) Ƣ б(University of Tubingen) 㸦 ܽ ǰ ġ Ȯߴ. 㿡 Ĵ 絵 Կ. ٸ, 㸦 쿡 ϰ, ٸ Ʋ ƹ ͵ ʰ ϴ ŭ ϴ 5:2 ܽ ״. , 絵 ü߰ ü ϸ ̻ 氣(MASH) ϴ 巯. ݸ, 5:2 ܽ Ծ ü ʾ, ջ Ÿ ġ Ҵ. ⼭ ָ 㰡 Įθ ѷ ߴٴ ̴. ܽ ߿ Ͽ Ʋ 5:2 ܽ Ϸ縦 ٸ º ȿ̶ ´. Ȯ Ŀ Ȯϱ ܹ Ȱ ߴ. , ܽ ϸ ؿ ִ Żռ(Gluconeogenesis) þ ϴ PPAR PCK1 ȿҵ Ȱȭȴٴ ߰ߴ. Ĵ ̹ MASH ߺ 5:2 ܽ 4 ϴ ߰ ߴ. , ܽ 氣 ġ ߺ پ Ÿ.
|
|
|
|
|
|
|
|